ADM

Archer-Daniels-Midland Co. 10-Q Summary

Business Context and Reporting Period

This is a Quarterly Report (Form 10-Q) for Archer-Daniels-Midland Company (ADM) for the period ended September 30, 2001. ADM is principally engaged in procuring, transporting, storing, processing, and merchandising agricultural commodities and products. Operations are classified into two reportable segments: Oilseeds & Corn Processing and Agricultural Services, with remaining operations in an "Other" segment.

Key Financial Metrics

Segment Performance (Operating Profit):

• Oilseeds & Corn Processing: $171.7 million (vs. $72.3 million in Q3 2000)
• Agricultural Services: $15.9 million (vs. $11.9 million in Q3 2000)
• Other: $33.6 million (vs. $133.5 million in Q3 2000)

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 19% to $5.5 billion, driven principally by recently acquired grain, feed, oilseeds, and cocoa operations, and to a lesser extent, increased sales volumes.
• Profitability: Net earnings rose 20% to $131.6 million. Gross profit increased $122 million, primarily due to improved margins in Oilseeds & Corn Processing (higher protein meal demand, lower net corn costs, and improved ethanol prices).
• Segment Shifts: The "Other" segment operating profit declined significantly compared to the prior year, largely due to the absence of a one-time $95 million gain from an affiliate (CIP) in the prior period and lower valuations of private equity fund investments.
• Expenses: Cost of products sold increased $748 million due to acquisitions and higher raw commodity prices. Selling, general, and administrative expenses rose $15 million, mostly attributable to acquired operations.
• Liquidity: Cash and cash equivalents decreased by $148 million during the quarter, primarily due to financing activities (repayment of credit lines and dividends) and changes in working capital (increases in receivables and inventories).

Guidance, Outlook, Risks, and Contingencies

Management Commentary: Management notes that operating results for the quarter are not necessarily indicative of full-year results. The company maintains substantial liquidity with working capital of $2.6 billion and a long-term debt to total capital ratio of approximately 32%.

Legal and Regulatory Risks:

• Antitrust Litigation: ADM is a defendant in numerous antitrust suits globally regarding lysine, citric acid, high fructose corn syrup (HFCS), and monosodium glutamate.
  • European Union: Fines of EUR 47.3 million (lysine) and EUR 10.3 million (sodium gluconate) have been imposed; ADM intends to appeal both.
  • United States: Summary judgment was granted to defendants in federal HFCS class actions, though plaintiffs have appealed. Various state and Canadian class actions remain pending or in settlement phases.
• Environmental Matters: Proceedings are ongoing with the Illinois EPA and U.S. EPA regarding permit violations and emissions. A Brazilian environmental penalty was successfully appealed to zero, though a reforestation project costing ~$200,000 is required. Management believes these matters will not have a material adverse effect.

Accounting Changes: The company will adopt SFAS 142 (Goodwill and Other Intangible Assets) in fiscal 2003, which will stop the amortization of goodwill but require annual impairment testing. The impact of this adoption has not yet been determined.

Investor Verification Checklist

• Verify the status and potential financial impact of the pending appeals regarding the EUR 57.6 million in European antitrust fines.
• Monitor the outcome of the federal appeal in the High Fructose Corn Syrup antitrust litigation, as the summary judgment dismissal is currently under review.
• Assess the sustainability of the improved margins in the Oilseeds & Corn Processing segment given the volatility of raw agricultural commodity prices.
• Review the valuation of private equity fund investments, which contributed to the decline in the "Other" segment's operating profit.
• Confirm the timeline and cost implications of the upcoming adoption of SFAS 142 regarding goodwill impairment testing.